| Period Ending | Mar 31, 2010 | Mar 31, 2009 | Mar 31, 2008 | Mar 31, 2007 |
|---|
|
Total Revenue
|
78,509,000
|
104,314,000
|
146,839,000
|
40,533,000
| | Cost of Revenue | 26,706,000 | 33,131,000 | 40,281,000 | 7,424,000 | | |
Gross Profit
|
51,803,000
|
71,183,000
|
106,558,000
|
33,109,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 41,218,000 | 46,488,000 | 47,811,000 | 11,990,000 | | | |
Operating Income or Loss
|
37,291,000
|
57,825,000
|
99,028,000
|
28,544,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 37,291,000 | 57,825,000 | 99,028,000 | 28,544,000 |
|
Interest Expense | (9,743,000) | (4,533,000) | (2,536,000) | (2,300,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 7,810,000 | 6,813,000 | 17,374,000 | 6,042,000 |
|
Minority Interest | 108,000 | (275,000) | (355,000) | (11,000) |
|
|
|
Net Income From Continuing Ops | 17,211,000 | 44,694,000 | 78,120,000 | 19,336,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
17,198,000
|
44,696,000
|
78,120,000
|
19,336,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
1.20%